Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome

References

• Alvarez-Blasco F, Botella-Carretero J I, San Millan J L, Escobar-Morreale H F. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med 2006; 166: 2081–2086
   PubMedGoogle Scholar
• Carmina E, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 2006; 86(Suppl 1)S7–S8
   PubMedGoogle Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25
   PubMed Web of Science ®Google Scholar
• Zawadzki J K DA. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic ovary syndrome, A Dunaif, J R Givens, F Haseltine, G R Merriam. Blackwell, Boston, MA 1992; 377–384
   Google Scholar
• Chang W Y, Knochenhauer E S, Bartolucci A A, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83: 1717–1723
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2006; 86(Suppl 1)S13–S14
   PubMed Web of Science ®Google Scholar
• Davison S, Davis S R. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003; 88: 2470–2478
   PubMed Web of Science ®Google Scholar
• Ridker P M, Hennekens C H, Buring J E, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836–843
   PubMed Web of Science ®Google Scholar
• Puder J J, Varga S, Kraenzlin M, De Geyter C, Keller U, Muller B. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 2005; 90: 6014–6021
   PubMed Web of Science ®Google Scholar
• Kelly C C, Lyall H, Petrie J R, Gould G W, Connell J M, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001; 86: 2453–2455
   PubMed Web of Science ®Google Scholar
• Vgontzas A N, Trakada G, Bixler E O, Lin H M, Pejovic S, Zoumakis E, Chrousos G P, Legro R S. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism 2006; 55: 1076–1082
   PubMed Web of Science ®Google Scholar
• Orio F, Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanova L, Nardo L G, Labella D, Savastano S, Russo T, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 2–5
   PubMed Web of Science ®Google Scholar
• Ehrmann D A, Liljenquist D R, Kasza K, Azziz R, Legro R S, Ghazzi M N. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 48–53
   PubMed Web of Science ®Google Scholar
• Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia D H. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005; 106: 131–137
   PubMed Web of Science ®Google Scholar
• Apridonidze T, Essah P A, Iuorno M J, Nestler J E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 1929–1935
   PubMed Web of Science ®Google Scholar
• Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli-Labate A M, Pagotto U, Pasquali R. Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes 2004; 53: 2353–2358
   PubMed Web of Science ®Google Scholar
• Legro R S, Kunselman A R, Dodson W C, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165–169
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774–800
   PubMed Web of Science ®Google Scholar
• Lo J C, Feigenbaum S L, Escobar G J, Yang J, Crites Y M, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care 2006; 29: 1915–1917
   PubMed Web of Science ®Google Scholar
• Radon P A, McMahon M J, Meyer W R. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999; 94: 194–197
   PubMed Web of Science ®Google Scholar
• Heitritter S M, Solomon C G, Mitchell G F, Skali-Ounis N, Seely E W. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2005; 90: 3983–3988
   PubMed Web of Science ®Google Scholar
• Di Benedetto A, Russo G T, Corrado F, Di Cesare E, Alessi E, Nicocia G, D'Anna R, Cucinotta D. Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Invest 2005; 28: 34–38
   PubMedGoogle Scholar
• Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004; 27: 1721–1727
   PubMed Web of Science ®Google Scholar
• Kousta E, Efstathiadou Z, Lawrence N J, Jeffs J A, Godsland I F, Barrett S C, Dore C J, Penny A, Anyaoku V, Millauer B A, et al. The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes. Diabetologia 2006; 49: 36–40
   PubMed Web of Science ®Google Scholar
• Metzger B E, Cho N H, Roston S M, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993; 16: 1598–1605
   PubMed Web of Science ®Google Scholar
• Kaufmann R C, Schleyhahn F T, Huffman D G, Amankwah K S. Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am J Obstet Gynecol 1995; 172: 621–625
   PubMed Web of Science ®Google Scholar
• Koivunen R M, Juutinen J, Vauhkonen I, Morin-Papunen L C, Ruokonen A, Tapanainen J S. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab 2001; 86: 2591–2599
   Google Scholar
• Holte J, Gennarelli G, Wide L, Lithell H, Berne C. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 1143–1150
   PubMed Web of Science ®Google Scholar
• Anttila L, Karjala K, Penttila R A, Ruutiainen K, Ekblad U. Polycystic ovaries in women with gestational diabetes. Obstet Gynecol 1998; 92: 13–16
   PubMed Web of Science ®Google Scholar
• Gestational diabetes mellitus. Diabetes Care 2004; 27(Suppl 1)S88–S90
   PubMed Web of Science ®Google Scholar
• Voigt M SK, Jährig K. Analyse des Geburtsgutes des Jahrgangs 1992 der Bundesrepublik Deutschland. Teil 1: Neue Perzentilwerte für die Körpermasse von Neugeborenen. Geburtshilfe Frauenheilkd 1996; 56: 550–558
   PubMed Web of Science ®Google Scholar
• Blum C A, Muller B, Huber P, Kraenzlin M, Schindler C, De Geyter C, Keller U, Puder J J. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab 2005; 90: 3230–3225
   PubMedGoogle Scholar
• Puder J J, Blum C A, Mueller B, Geyter C, Dye L, Keller U. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur J Clin Invest 2006; 36: 58–64
   PubMed Web of Science ®Google Scholar
• Puder J J, Varga S, Nusbaumer C P, Zulewski H, Bilz S, Muller B, Keller U. Women with polycystic ovary syndrome are sensitive to the TNF-α-lowering effect of glucose-induced hyperinsulinaemia. Eur J Clin Invest 2006; 36: 883–889
   Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421
   PubMed Web of Science ®Google Scholar
• Hatch R, Rosenfield R L, Kim M H, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815–830
   PubMed Web of Science ®Google Scholar
• Moriconi N, Kraenzlin M, Muller B, Keller U, Nusbaumer C P, Stohr S, Tamm M, Puder J J. Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis. J Clin Endocrinol Metab 2006; 91: 1586–1590
   Google Scholar
• Hadigan C, Miller K, Corcoran C, Anderson E, Basgoz N, Grinspoon S. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1999; 84: 1932–1937
   PubMed Web of Science ®Google Scholar
• Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Carmina E, Chu M C, Longo R A, Rini G B, Lobo R A. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 2005; 90: 2545–2549
   PubMed Web of Science ®Google Scholar
• de Zegher F, Ibanez L. Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome. Fertil Steril 2006; 86(Suppl 1)S4–S5
   Google Scholar
• Codner E, Escobar-Morreale H F. Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2007; 92: 1209–1216
   Google Scholar
• de Boer J A, Lambalk C B, Hendriks H H, van Aken C, van der Veen E A, Schoemaker J. Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome. Hum Reprod 2004; 19: 504–509
   Google Scholar
• Premoli A C, Santana L F, Ferriani R A, Moura M D, De Sa M F, Reis R M. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome. Fertil Steril 2005; 83: 1852–1855
   PubMedGoogle Scholar
• Abbasi F, Reaven G M. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002; 51: 235–237
   PubMed Web of Science ®Google Scholar
• Mooy J M, Grootenhuis P A, de Vries H, Kostense P J, Popp-Snijders C, Bouter L M, Heine R J. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996; 39: 298–305
   PubMed Web of Science ®Google Scholar
• Kajaia N, Binder H, Dittrich R, Oppelt P G, Flor B, Cupisti S, Beckmann M W, Mueller A. Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome. Eur J Endocrinol 2007; 157: 499–507
   Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley R E, Tataranni P A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–1935
   PubMed Web of Science ®Google Scholar
• Aroda V, Ciaraldi T P, Chang S A, Dahan M H, Chang R J, Henry R R. Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action. Fertil Steril, Aug 11 [Epub ahead of print]
   Google Scholar
• Shand B, Elder P, Scott R, Frampton C, Willis J. Biovariability of plasma adiponectin. Clin Chem Lab Med 2006; 44: 1264–1268
   Google Scholar
• Spranger J, Mohlig M, Wegewitz U, Ristow M, Pfeiffer A F, Schill T, Schlosser H W, Brabant G, Schofl C. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004; 61: 738–746
   PubMed Web of Science ®Google Scholar